Publications by authors named "Yuichi Kakoi"

Claim this Profile
C
CDK8/19 inhibition induces premature G1/S transition and ATR-dependent cell death in prostate cancer cells.
Akito Nakamura, Daisuke Nakata, Yuichi Kakoi, Mihoko Kunitomo, Saomi Murai

Oncotarget· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities.
Yoshiko Awazu, Kazuhide Nakamura, Akio Mizutani, Yuichi Kakoi, Hidehisa Iwata

Mol Cancer Ther· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-angiogenic and anti-tumor effects of TAK-593, a potent and selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinase.
Yoshiko Awazu, Akio Mizutani, Yoshinori Nagase, Shuntarou Tsuchiya, Kazuhide Nakamura, Yuichi Kakoi

Cancer Sci· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a potent and orally available acyl-CoA: cholesterol acyltransferase inhibitor as an anti-atherosclerotic agent: (4-phenylcoumarin)acetanilide derivatives.
Masaki Ogino, Seiji Fukui, Yoshihisa Nakada, Ryosuke Tokunoh, Shigekazu Itokawa, Yuichi Kakoi

Chem Pharm Bull (Tokyo)· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis